Ausgabe 4/2022
Inhalt (12 Artikel)
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation
Dominick J. Angiolillo, Jayne Prats, Efthymios N. Deliargyris, David J Schneider, James Scheiman, Carey Kimmelstiel, Ph. Gabriel Steg, Mark Alberts, Todd Rosengart, Roxana Mehran, Deepak L. Bhatt
Pharmacokinetics and Pharmacodynamics of Tedizolid
Khalid Iqbal, Aliki Milioudi, Sebastian Georg Wicha
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency
Pier Giorgio Cojutti, Ezio Zanon, Samantha Pasca, Federico Pea, Laura Banov, Chiara Biasioli, Patrizia Di Gregorio, Antonietta Ferretti, Angelo Claudio Molinari, Lucia Dora Notarangelo, Roberta Palla, Flora Peyvandi, Michele Pizzuti, Berardino Pollio, Gianluca Sottilotta, Simona Maria Siboni
Population Pharmacokinetic Analysis to Assist Dose Selection of the l-Ornithine Salt of Phenylacetic Acid
Xiaofeng Wang, Regis A. Vilchez
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer
C. Louwrens Braal, Agnes Jager, Esther Oomen-de Hoop, Justin D. Westenberg, Koen M. W. T. Lommen, Peter de Bruijn, Mijntje B. Vastbinder, Quirine C. van Rossum-Schornagel, Martine F. Thijs-Visser, Robbert J. van Alphen, Liesbeth E. M. Struik, Hanneke J. M. Zuetenhorst, Ron H. J. Mathijssen, Stijn L. W. Koolen
Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
Eric Wenzler, David Butler, Xing Tan, Takayuki Katsube, Toshihiro Wajima
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens
Gunjan L. Shah, Jaap Jan Boelens, Dean Carlow, Andrew Lin, Ryan Schofield, Nancy Cruz Sitner, Anna Alperovich, Josel Ruiz, Anthony Proli, Parastoo Dahi, Roni Tamari, Sergio A. Giralt, Michael Scordo, Rick Admiraal
Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment
Christian Zurth, Pirjo Nykänen, Gary Wilkinson, Päivi Taavitsainen, Annamari Vuorela, Funan Huang, Susanne Reschke, Mikko Koskinen
Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids
Denise Beck, Insa Winzenborg, Mohan Liu, Jacob Degner, Nael M. Mostafa, Peter Noertersheuser, Mohamad Shebley
Correction to: Unbound Plasma, Total Plasma and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation
Maaike A. Sikma, Erik M. Van Maarseveen, Claudine C. Hunault, Javier M. Moreno, Ed A. Van de Graaf, Johannes H. Kirkels, Marianne C. Verhaar, Jan C. Grutters, Jozef Kesecioglu, Dylan W. De Lange, Alwin D. R. Huitema
Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis
Jessica Wojciechowski, Bimal K. Malhotra, Xiaoxing Wang, Luke Fostvedt, Hernan Valdez, Timothy Nicholas